Impact of diabetes-associated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 1, 2002, Pages 286-291

  Ren, Song ^a   Lee, Harvey ^b   Hu, Limei ^a   Lu, Lin ^b   Shen, Garry X ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Rossmere Medical Clinic   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIUM CELL; FEMALE; FIBRINOLYSIS; GENE ACTIVATION; HEMOSTASIS; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; THROMBOSIS; UMBILICAL VEIN;

EID: 0036146433     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.1.8175     Document Type: Article

References (35)

1. Epidemiology of type 2 diabetes mellitus in North America
2. Endothelial function in health and disease: New insights into the genesis of cardiovascular disease
3. Endothelial cell dysfunction and the pathogenesis of diabetic macroangiopathy
4. Blood fibrinolytic activity in diabetes mellitus and its bearing on ischaemic heart disease and obesity
5. Platelet adhesiveness, plasma fibrinogen, and fibrinolytic activity in juvenile-onset and maturity-onset diabetes mellitus
6. The relationship between plasminogen activator inhibitor-1 and insulin resistence in newly diagnosed type 2 diabetes mellitus
7. Activity of tissue plasminogen activator and plasminogen activator inhibitor in noninsulin-dependent diabetes mellitus
8. Glycosylation of low density lipoprotein in patients with type I (insulin-dependent) diabetes: Correlation with other parameters of glycaemic control
9. Influence of glycation on LDL-induced generation of fibrinolytic regulators in vascular endothelial cells
10. Very low density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia
11. Clinical practice guidelines for the management of diabetes in Canada
12. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
13. Conversion of 15-hydroxyeicosatetraenoic acid to 11-hydroxyhexadecatrienoic acid by endothelial cells
14. Impact of antioxidants and HDL on glycated LDL-induced generation of fibrinolytic regulators from vascular endothelial cells
15. Growth hormone modulates insulin regulation of hepatic insulin-like growth factor binding protein-1 transcription
16. Differential expression of human placental growth hormone variant and chorionic somatomammotropin in cultures
17. Stimulating effect of oxidized low density lipoprotein on plasminogen activator inhibitor-1 synthesis by endothelial cells
18. Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs. An LDL receptor-independent phenomenon
19. Oxidative modification enhances lipoprotein(a)-induced overproduction of plasminogen activator inhibitor-1 in cultured vascular endothelial cells
20. Effects of native, triglyceride-enriched, and oxidatively modified LDL on plasminogen activator inhibitor-1 expression in human endothelial cells
21. Plasma triglyceride and coronary artery disease
22. Why are low-density lipoproteins atherogenic?
23. Glycosylation of low density lipoprotein in patients with type I (insulin-dependent) diabetes: Correlation with other parameters of glycaemic control
24. Glycation accelerates the oxidation of low density by copper ions
25. High-density lipoprotein as a protective factor against coronary heart disease: The Framingham study
26. ACE-inhibition modulates some endothelial functions in health subjects and in normotensive type 1 diabetic patients
27. Fosinopril decreases levels of soluble vascular cell adhesion molecule-1 in borderline hypertensive type II diabetic patients with microalbuminuria
28. The relationship between plasminogen activa for inhibitor-1 and insulin resistance in newly diagnosed type 2 diabetes mellitus
29. Stimulation by proinsulin of expression of plasminogen activator inhibitor 1 in endothelial cells
30. The metablic effects of biosynthetic human proinsulin in individuals with type 1 diabetes
31. Stimulation by proinsulin of expression of plasminogen activator typed-1 in endothelial cells
32. Augmentation of synthesis of plasminogen activator inhibitor typed in arterial endothelial cells by glucose and its implication for local fibrinolysis
33. Plasminogen activator inhibitor-1 expression by brain microvascular endothelial cells is inhibited by elevated glucose
34. The effects of high- and medium-dose metformin therapy on cardiovascular risk factors in patients with type II diabetes